Showing results (51-60 of 164) with videos related to
Sort By:
Pageof 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2020
Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?Mathilde Ruggiu, Bruno Cassinat, Jean-Jacques Kiladjian, et al.Annales Pharmaceutiques Francaises|October 10, 2025
The evolving role of Hospital Oncology Pharmacists (HOPs) in assessing therapeutic innovations and managing toxicities in cancer careFlorence Ranchon, Florian Slimano, Maha Ayyoub, et al.Leukemia & Lymphoma|December 8, 2011
Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trialGiovanna Cannas, Cécile Pautas, Emmanuel Raffoux, et al.The Journal of Experimental Medicine|November 20, 2002
In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemiaMarie-Claude Guillemin, Emmanuel Raffoux, Dominique Vitoux, et al.Leukemia & Lymphoma|November 6, 2020
Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adultsMarie-Anne Couturier, Xavier Thomas, Emmanuel Raffoux, et al.Biochemical Pharmacology|November 6, 2003
Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib (Gleevec) in vitro and in vivoJérôme Larghero, Thibaut Leguay, Samia Mourah, et al.Haematologica|July 11, 2019
Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activationLaetitia Boutin, Pierre Arnautou, Aurélie Trignol, et al.Blood|February 23, 2008
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trialsNathalie Mourad, Nicolas Mounier, Josette Brière, et al.Bone Marrow Transplantation|June 2, 2022
Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantationAurélien Sutra Del Galy, Adrien Rousseau, Antoine Capes, et al.Leukemia & Lymphoma|June 9, 2020
Ponatinib-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the real-life OPAL studySuzanne Tavitian, Madalina Uzunov, Emilie Bérard, et al.Pageof 17